Vident Advisory, LLC

Position in ZTS — Zoetis Inc.

CIK 1744347 Alpharetta, GA

Position in ZTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,230,847

-$130,989 QoQ

Shares Held

52,710

+4.2% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 46.67804970593815.ToString("F0")% Shared 0.ToString("F0")% None 53.32195029406185.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vident Advisory, LLC holds $33,979,992 across 23 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (18.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	52,710	$6,230,847
2	VTRS	Viatris Inc	350,648	$4,737,253
3	UTHR	UNITED THERAPEUTICS Corp	6,039	$3,581,004
4	RDY	Dr Reddys Laboratories Ltd	217,581	$3,013,496
5	ALKS	Alkermes plc.	84,090	$2,973,422
6	HLN	Haleon plc	235,522	$2,357,574
7	TEVA	Teva Pharmaceutical Industries Ltd	49,744	$1,498,288
8	TAK	Takeda Pharmaceutical Co Ltd	75,036	$1,389,666

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,230,847	52,710	+4.2%	Shares	Sole	2026-05-15
2025-12-31	$6,361,836	50,563	-5.0%	Shares	Defined	2026-02-18
2025-09-30	$7,787,295	53,221	+13.6%	Shares	Defined	2025-11-14
2025-06-30	$7,308,283	46,863	-42.2%	Shares	Sole	2025-08-14
2025-03-31	$13,359,864	81,141	+135.3%	Shares	Defined	2025-05-15
2024-12-31	$5,618,151	34,482	+4.8%	Shares	Defined	2025-02-14
2024-09-30	$6,431,517	32,918	-13.4%	Shares	Sole	2024-11-14
2024-06-30	$6,590,106	38,014	-1.3%	Shares	Sole	2024-08-14
2024-03-31	$6,516,784	38,513	-4.4%	Shares	Sole	2024-05-14
2023-12-31	$7,948,088	40,270	+14.6%	Shares	Sole	2024-02-14
2023-09-30	$6,114,004	35,142	—	Shares	Defined	2024-02-21
No filing history on record for this holder in this stock.